about
A technical approach for optimizing surveillance of patients with unstable coronary syndromes: continuous vectorcardiography ischemic monitoring.The Western Denmark Cardiac Computed Tomography Registry: a review and validation study.Noninvasive Fractional Flow Reserve for the Diagnosis of Lesion-specific Ischemia: A Case Example.Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan.Transcatheter aortic valve implantation in a young heart transplant recipient crossing the traditional boundaries.Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysisFractional flow reserve derived from coronary CT angiography in stable coronary disease: a new standard in non-invasive testing?Image-based assessment of fractional flow reserve.Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts study.Multimodality cardiac imaging in Turner syndrome.Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study.Left and right ventricular lead positions are imprecisely determined by fluoroscopy in cardiac resynchronization therapy: a comparison with cardiac computed tomography.Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFRCT RIPCORD Study.Frontline diagnostic evaluation of patients suspected of angina by coronary computed tomography reduces downstream resource utilization when compared to conventional ischemia testing.Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction.The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy.Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration.Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease.Coronary artery anomalies in Turner Syndrome.Late Obstructive Transcatheter Heart Valve Thrombosis Resolved by Rivaroxaban.Prosthetic valve endocarditis after transcatheter aortic valve implantation-diagnostic and surgical considerations.Severe aortic coarctation in an adult patient with normal brachial blood pressureCoronary artery calcification and ECG pattern of left ventricular hypertrophy or strain identify different healthy individuals at risk.Which exercise test to use for chest pain from an anomalous coronary artery.Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement.Diagnostic accuracy and discrimination of ischemia by fractional flow reserve CT using a clinical use rule: results from the Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography study.1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study).Left atrial size and function as assessed by computed tomography in cardiac resynchronization therapy: Association to echocardiographic and clinical outcome.Fractional flow reserve derived from coronary computed tomography angiography reclassification rate using value distal to lesion compared to lowest value.High burden of coronary atherosclerosis in patients with cirrhosis.Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.Risk prediction in acute coronary syndrome from serial in-hospital measurements of N-terminal pro-B-type natriuretic peptide.Sex difference in clot lysability and association to coronary artery calcification.High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes.Coronary CT angiography in clinical practice: experiences from Denmark.Factor VII-activating protease: sex-related association with coronary artery calcification.Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement.Fracturing the Ring of Small Mitroflow Bioprostheses by High-Pressure Balloon Predilatation in Transcatheter Aortic Valve-in-Valve Implantation.
P50
Q34201818-1E745957-F194-46EE-B8DC-E85C8FE09B42Q35049366-905E2389-8FE1-4321-9F26-03CFF6C19585Q35065796-E02FBE8C-1E23-43CF-9229-F588A7C48F06Q36069839-848664C7-8571-4FEB-92B6-BF5D5834A291Q37208727-179E09EE-22D6-4B5A-9402-1AF33B37946BQ37738590-E3AA9CBD-182D-4F56-A0FB-F94C68AE29B5Q38355038-165E6FA5-A888-4AB6-BA2C-E2826219212DQ38486778-8BE07DC1-E403-4CC9-BC42-D18992EFE6C3Q38589186-C5410A0C-E5C5-4E1E-8D7C-77283569F9D9Q38722261-3D635E94-E312-42B7-9CF0-387F0D6A50B1Q38820566-001B1867-D335-4988-86EB-496D1532226BQ39218603-62726A0B-F9D8-47D6-A069-7DCFEEC24159Q39446661-8AC68ED4-B044-421C-BDA9-8FF3551BACA9Q39821542-B266EEFC-0483-4BB0-863B-1C44EEF4ACEAQ39961924-BE680B13-246D-415C-8A9D-F71E94262161Q40008061-A750D11D-DE98-43B3-9EC6-A80F70A32F06Q40016673-B163C4E1-6955-444B-84AA-C18322F76B53Q40254399-66E0FAFE-E501-4BAA-8FAF-BD207D389E32Q40623005-084A9F91-8C4D-43D5-B809-00FB7D6BBDF5Q42231408-243FED62-9710-42D7-8187-7875F1E7743AQ42369317-08CDA4FF-0058-4E58-86BF-A75ECFD04293Q42836947-8B653F89-293C-46E4-9D23-0CF084EC0BF2Q43938013-3148C779-9DAD-4C65-A7CD-1C060CEB9818Q43947253-0D29A6DF-0771-4473-95E9-440C1D4A8DD4Q44385034-6591E163-C9F6-48CA-8088-02FD5C3468ADQ45939978-592AE3BA-4D25-488A-A0EC-BCBC2488B7EAQ46456144-7D0B1C6A-C260-4A3D-A79A-5E60F5FC73C9Q46755200-0472DFE4-CC2D-4956-9F4C-A820CCFDB506Q47240248-7D3ED2E7-B9ED-4419-943A-E4D0AC38F916Q47848073-79CB403C-110E-4D0F-BA68-95BBB2F038D0Q48212374-7A6F7C5E-56F6-4417-8295-AB1BE6C400FFQ48504851-AB9E4C59-9268-47DE-8A0C-5E042CBCA945Q48590115-30C59272-1C89-4089-A85D-7E1A1BF3476BQ49111539-E4ED8793-40B9-458C-BB1E-76EE7D7B4B63Q49310158-C9BFC809-3050-4584-BF2B-A39AE8DF40F4Q50229865-2F722544-5ABC-45EC-B987-DBDA60E56D9DQ50562284-897B1C7F-0ADF-4B07-836A-C13BFF48704AQ50977465-B019D8B2-CC93-4852-A466-E3A41E6E4FCCQ51773247-C7B6BCF7-57D1-4F1D-9432-90345D7F732FQ51835157-686229B5-7D14-42C2-91FA-CBB621BC4B32
P50
description
researcher
@en
wetenschapper
@nl
name
B L Nørgaard
@en
B L Nørgaard
@nl
type
label
B L Nørgaard
@en
B L Nørgaard
@nl
prefLabel
B L Nørgaard
@en
B L Nørgaard
@nl
P106
P31
P496
0000-0002-4758-7203